Literature DB >> 19751407

Inhibition of TNF-alpha-induced activation of NF-kappaB by hantavirus nucleocapsid proteins.

Shannon L Taylor1, Ryan L Krempel, Connie S Schmaljohn.   

Abstract

Hantaviruses cause two human diseases thought to be immune-mediated: hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS). We recently reported that the nucleocapsid (N) protein of HFRS-causing Hantaan virus (HTNV) inhibits tumor necrosis factor-alpha (TNF-alpha) activation of nuclear factor-kappaB (NF-kappaB). Here we measured the ability of other hantaviral N proteins to similarly interfere with the inflammatory process of TNF-alpha. We found that like HTNV N, the N proteins of HFRS-causing Seoul and Dobrava viruses inhibited TNF-alpha activation of NF-kappaB and translocation of the NF-kappaB p65 subunit, but did not interfere with degradation of inhibitor of NF-kappaB (IkappaB). In contrast, the HFRS-causing Puumala virus and the HPS-causing Andes and Sin Nombre viruses did not prevent TNF-alpha activation of NF-kappaB or nuclear translocation of p65. These studies provide evidence that hantaviruses differ in their abilities to interfere with host innate immune responses.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19751407     DOI: 10.1111/j.1749-6632.2009.05049.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  21 in total

1.  Signatures of host mRNA 5' terminus for efficient hantavirus cap snatching.

Authors:  Erdong Cheng; Mohammad A Mir
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

2.  Genetic reassortment between high-virulent and low-virulent Dobrava-Belgrade virus strains.

Authors:  Sina Kirsanovs; Boris Klempa; Renate Franke; Min-Hi Lee; Günther Schönrich; Andreas Rang; Detlev H Kruger
Journal:  Virus Genes       Date:  2010-08-24       Impact factor: 2.332

3.  Hantavirus nucleocapsid protein has distinct m7G cap- and RNA-binding sites.

Authors:  Mohammad A Mir; Sheema Sheema; Abdul Haseeb; Absarul Haque
Journal:  J Biol Chem       Date:  2010-02-17       Impact factor: 5.157

4.  Ribosomal protein S19-binding domain provides insights into hantavirus nucleocapsid protein-mediated translation initiation mechanism.

Authors:  Safder S Ganaie; Absarul Haque; Erdong Cheng; Tania S Bonny; Nilshad N Salim; Mohammad A Mir
Journal:  Biochem J       Date:  2014-11-15       Impact factor: 3.857

Review 5.  A global perspective on hantavirus ecology, epidemiology, and disease.

Authors:  Colleen B Jonsson; Luiz Tadeu Moraes Figueiredo; Olli Vapalahti
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

6.  The C-terminal 42 residues of the Tula virus Gn protein regulate interferon induction.

Authors:  Valery Matthys; Elena E Gorbunova; Irina N Gavrilovskaya; Timothy Pepini; Erich R Mackow
Journal:  J Virol       Date:  2011-03-02       Impact factor: 5.103

7.  The murine model for Hantaan virus-induced lethal disease shows two distinct paths in viral evolutionary trajectory with and without ribavirin treatment.

Authors:  Dong-Hoon Chung; Åke Västermark; Jeremy V Camp; Ryan McAllister; Susanna K Remold; Yong-Kyu Chu; Carl Bruder; Colleen B Jonsson
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

8.  Characterization of the Interaction between hantavirus nucleocapsid protein (N) and ribosomal protein S19 (RPS19).

Authors:  Erdong Cheng; Absarul Haque; Mary Ashley Rimmer; Islam T M Hussein; Sheema Sheema; Alex Little; Mohammad A Mir
Journal:  J Biol Chem       Date:  2011-02-04       Impact factor: 5.157

9.  T cells are not required for pathogenesis in the Syrian hamster model of hantavirus pulmonary syndrome.

Authors:  Christopher D Hammerbeck; Jay W Hooper
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

10.  Crystal Structure of the Core Region of Hantavirus Nucleocapsid Protein Reveals the Mechanism for Ribonucleoprotein Complex Formation.

Authors:  Yu Guo; Wenming Wang; Yuna Sun; Chao Ma; Xu Wang; Xin Wang; Pi Liu; Shu Shen; Baobin Li; Jianping Lin; Fei Deng; Hualin Wang; Zhiyong Lou
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.